The dysregulated NLRP3 activation is a critical mechanism in several serious neonatal diseases characterized by intense inflammation, such as hypoxic–ischemic encephalopathy (HIE), bronchopulmonary dysplasia, sepsis, and necrotizing enterocolitis. This evidence concerns the gene NLRP3 and bronchopulmonary dysplasia.